Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblastsZhite Zhao, Changhong Shi, Tong Lü et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 13